Browsing by Author Colquhoun, David

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 21  next >
Issue DateTitleAuthor(s)Citation
2014Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients with Statin Intolerance: The GAUSS-2 Randomized, Placebo-controlled Phase 3 Clinical Trial of EvolocumabSullivan, David; Bruckert, Eric; Cho, Leslie; Civeira, Fernando; Colquhoun, David; Dent, Ricardo; et al, Various; Knusel, Beat; Rosenson, Robert S; Stroes, Erik; Watts, Gerald F; School of Public Health: NH&MRC Clinical Trials CentreAnti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients with Statin Intolerance: The GAUSS-2 Randomized, Placebo-controlled Phase 3 Clinical Trial of Evolocumab, Journal of the American College of Cardiology, vol.63, 23, 2014,pp 2541-2548
2014Association of Contemporary Sensitive Troponin I Levels at Baseline and Change at 1 Year With Long - Term Coronary Events Following Myocardial Infarction or Unstable AnginaKeech, Anthony (Tony); Mann, Kristy; Simes, Robert John; Blankenberg, Stefan; Colquhoun, David; Hunt, David; Nestel, Paul; Stewart, Ralph A.H.; Sullivan, David; Thompson, Peter; Tonkin, Andrew; West, Malcolm; White, Harvey D.; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreAssociation of Contemporary Sensitive Troponin I Levels at Baseline and Change at 1 Year With Long - Term Coronary Events Following Myocardial Infarction or Unstable Angina, Journal of the American College of Cardiology, vol.63, 4, 2014,pp 345-354
2015Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker studyHague, Wendy; Keech, Anthony (Tony); Kirby, Adrienne; Simes, Robert John; Sullivan, David; Blankenberg, Stefan; Colquhoun, David; Funke-Kaiser, Anne; Hunt, David; Nestel, P; Stewart, Ralph; Thompson, Peter; Tonkin, Andrew; West, Malcolm; White, Harvey; Zeller, Tanja; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreBiomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker study, International Journal of Cardiology, vol.201, N/A, 2015,pp 499-507
2013Changes in lipoprotein-associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease studyBarnes, Elizabeth; Keech, Anthony (Tony); Marschner, Ian (Colin); Simes, Robert John; Sullivan, David; Blankenberg, Stefan; Colquhoun, David; Hunt, David; Nestel, Paul; Stewart, Ralph A.H.; Thompson, Peter; Tonkin, Andrew; West, Malcolm; White, Harvey D.; Zeller, Tanja; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreChanges in lipoprotein-associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease study, Journal of the American Heart Association, vol.2, 5, 2013,pp 1-12
2016Clinical Profile of Statin Intolerance in the Phase 3 GAUSS-2 StudySullivan, David; Cho, Leslie; Colquhoun, David; Dent, Ricardo; Rocco, Michael; Rosenson, Robert S; Scott, Rob; Stroes, Erik; Wasserman, Scott M; Xue, Allen; NH&MRC Clinical Trials CentreClinical Profile of Statin Intolerance in the Phase 3 GAUSS-2 Study, Cardiovascular Drugs and Therapy, vol.30, 3, 2016,pp 297-304
2003Depression and cardiovascular morbidity and mortality: cause or consequence?Simes, Robert John; Colquhoun, David; North, Fiona M.; Sharples, Katrina J.; Stewart, Ralph A.H.; Tonkin, Andrew M; West, Teena M.; White, Harvey D; School of Public Health: NH&MRC Clinical Trials CentreDepression and cardiovascular morbidity and mortality: cause or consequence?, European Heart Journal, vol.24,(N/A),2003,pp 2027-2037
2014Design and Rationale of the GAUSS-2 Study Trial: a Double-Blind, Ezetimibe-Controlled Phase 3 Study of the Efficacy and Tolerability of Evolocumab (AMG 145) in Subjects with Hypercholesterolemia Who Are Intolerant of Statin TherapySullivan, David; Cho, Leslie; Colquhoun, David; Dent, Ricardo; Rocco, Michael; Rosenson, Robert S; Scott, Rob; Stroes, Erik; Wasserman, Scott M; Xue, Allen; NH&MRC Clinical Trials CentreDesign and Rationale of the GAUSS-2 Study Trial: a Double-Blind, Ezetimibe-Controlled Phase 3 Study of the Efficacy and Tolerability of Evolocumab (AMG 145) in Subjects with Hypercholesterolemia Who Are Intolerant of Statin Therapy, Clinical Cardiology, vol.37, 3, 2014,pp 131-139
2004Effects Of Pravastatin On Coronary Events In 2073 Patients With Low Levels Of Both Low-Density Lipoprotein Cholesterol And High-Density Lipoprotein Cholesterol: Results From The Lipid Study.Barter, Philip; Keech, Anthony (Tony); Marschner, Ian; Simes, Robert John; Colquhoun, David; Glasziou, Paul; Hunt, David; Tonkin, Andrew; White, Harvey D.; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreEffects Of Pravastatin On Coronary Events In 2073 Patients With Low Levels Of Both Low-Density Lipoprotein Cholesterol And High-Density Lipoprotein Cholesterol: Results From The Lipid Study., European Heart Journal (2005), vol.25,(9),2004,pp 771-777
2016Improved persistence with non-vitamin-K oral anticoagulants compared with warfarin in patients with atrial fibrillation: recent Australian experienceFreedman, Ben; Colquhoun, David; Ortiz, Michael; Simons, Leon; Thomas, Gareth; Waterhouse, Benjamin; Concord Clinical School: ANZAC Research InstituteImproved persistence with non-vitamin-K oral anticoagulants compared with warfarin in patients with atrial fibrillation: recent Australian experience, Current Medical Research and Opinion, vol.32, 11, 2016,pp 1857-1861
2016Improved persistence with non-vitamin-K oral anticoagulants compared with warfarin in patients with atrial fibrillation: recent Australian experienceFreedman, Ben; Colquhoun, David; Ortiz, Michael; Simons, Leon; Thomas, Gareth; Waterhouse, Benjamin; Concord Clinical School: ANZAC Research InstituteImproved persistence with non-vitamin-K oral anticoagulants compared with warfarin in patients with atrial fibrillation: recent Australian experience, Current Medical Research and Opinion, vol.32, 11, 2016,pp 1857-1861
2015Indications for Omega-3 Long Chain Polyunsaturated Fatty Acid in the Prevention and Treatment of Cardiovascular DiseaseSullivan, David; Clifton, Peter; Colquhoun, David; Mori, Trevor A.; Nestel, Paul; Noakes, Manny; Thomas, Beth; NH&MRC Clinical Trials CentreIndications for Omega-3 Long Chain Polyunsaturated Fatty Acid in the Prevention and Treatment of Cardiovascular Disease, Heart, Lung and Circulation, vol.24, 8, 2015,pp 769-779
2002Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow upHague, Wendy; Keech, Anthony (Tony); Kirby, Adrienne; MacMahon, Stephen; Simes, Robert John; Alyward, P; Colquhoun, David; Glasziou, P; Hunt, D; Thompson, P; Tonkin, A; West, M; White, Harvey D.; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; The George Institute for International Health; School of Public Health: NH&MRC Clinical Trials CentreLong-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow up, The Lancet, vol.359,(N/A),2002,pp 1379-1387
2016Long-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart Disease: Sixteen Years of Follow-Up of the LIPID StudyHague, Wendy; Keech, Anthony (Tony); Kirby, Adrienne; Pater, Helen; Simes, Robert John; Sullivan, David; Colquhoun, David; Glasziou, Paul P; Hunt, David; Nestel, Paul; Stewart, Ralph A.H.; Thompson, Peter; Tonkin, Andrew M; West, Malcolm; White, H D; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreLong-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart Disease: Sixteen Years of Follow-Up of the LIPID Study, Circulation, vol.133, 19, 2016,pp 1851-1860
2016Long-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart Disease: Sixteen Years of Follow-Up of the LIPID StudyHague, Wendy; Keech, Anthony (Tony); Kirby, Adrienne; Pater, Helen; Simes, Robert John; Sullivan, David; Colquhoun, David; Glasziou, Paul P; Hunt, David; Nestel, Paul; Stewart, Ralph A.H.; Thompson, Peter; Tonkin, Andrew M; West, Malcolm; White, H D; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreLong-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart Disease: Sixteen Years of Follow-Up of the LIPID Study, Circulation, vol.133, 19, 2016,pp 1851-1860
2017Medium- to long-term persistence with non-vitamin-K oral anticoagulants in patients with atrial fibrillation: Australian experienceFreedman, Ben; Colquhoun, David; Ortiz, Michael; Simons, L; Waterhouse, Benjamin; Concord Clinical School: ANZAC Research InstituteMedium- to long-term persistence with non-vitamin-K oral anticoagulants in patients with atrial fibrillation: Australian experience, Current Medical Research and Opinion, vol.33, 7, 2017,pp 1337-1341
2014Midregional proadrenomedullin and its change predicts recurrent major coronary events and heart failure in stable coronary heart disease patients: the LIPID studyMann, Kristy; Simes, Robert John; Sullivan, David; Blankenberg, Stefan; Colquhoun, David; Funke-Kaiser, Anne; Hunt, David; Sydow, Karsten; Tonkin, Andrew M; West, Malcolm; White, Harvey; Zeller, Tanja; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreMidregional proadrenomedullin and its change predicts recurrent major coronary events and heart failure in stable coronary heart disease patients: the LIPID study, International Journal of Cardiology, vol.172, 2, 2014,pp 411-418
2006Neither plasma coenzyme Q(10) concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: A prospective case-control study from the LIPID study.Pollicino, Christine; Simes, Robert John; Stocker, Roland; Sullivan, David; Colquhoun, David; Gay, Craig A.; Nestel, Paul; Tonkin, Andrew; Whiting, Malcolm; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; School of Medical Sciences: Pathology; School of Molecular BioscienceNeither plasma coenzyme Q(10) concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: A prospective case-control study from the LIPID study., Atherosclerosis, vol.187,(1),2006,pp 198-204
2017Persistent psychological distress and mortality in patients with stable coronary artery diseaseGlozier, Nicholas; Kirby, Adrienne; Marschner, Simone; Simes, Robert John; Colquhoun, David; Nestel, P; O'Neil, Adrienne; Oldenburg, Brian F.; Stewart, Ralph; Tonkin, Andrew; White, Harvey D; Central Clinical School: Psychological Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentrePersistent psychological distress and mortality in patients with stable coronary artery disease, Heart, vol.103, 23, 2017,pp 1860-1866
2005Relation of diet to cardiovascular disease risk factors in subjects with cardiovascular disease in Australia and New Zealand: analysis of the Long-Term Intervention with Pravastatin in Ischaemic Disease trial.Kirby, Adrienne; Mehalski, Kirsty; Pollicino, Christine; Simes, Robert John; Baghurst, Katrine; Colquhoun, David; Nestel, Paul; Tonkin, Andrew; White, Harvey D.; School of Public Health: NH&MRC Clinical Trials Centre; School of Molecular Bioscience; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials CentreRelation of diet to cardiovascular disease risk factors in subjects with cardiovascular disease in Australia and New Zealand: analysis of the Long-Term Intervention with Pravastatin in Ischaemic Disease trial., American Journal of Clinical Nutrition, vol.81,(6),2005,pp 1322-1329
2003Secondary prevention of cardio vascular events with long-term Pravastatin in patients with diabetes or impared fasting glucoseArulchelvam, Manjula; Baker, Jane; Beller, Elaine; Hague, Wendy; Keech, Anthony (Tony); Kirby, Adrienne; Simes, Robert John; Best, James D.; Colquhoun, David; Hunt, David; Tonkin, Andrew; School of Public Health: NH&MRC Clinical Trials Centre; Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreSecondary prevention of cardio vascular events with long-term Pravastatin in patients with diabetes or impared fasting glucose, Diabetes Care, vol.26,(N/A),2003,pp 2713-2721